Profitelligence Profitelligence · Filing Ledger Open HIMS research →

Form 8-K · Current Report · Filed 2026-08-10

Hims & Hers Health Reports 38% Revenue Growth and Raises Guidance

Hims & Hers Health, Inc. reported a 38% year-over-year increase in revenue for the second quarter of 2026, reaching $753.2 million. The company also saw a 19% increase in subscribers, bringing the total to nearly 2.9 million. In response to these strong results, the company raised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion and updated its Adjusted EBITDA guidance to a range of $275 million to $325 million. The company's domestic revenue grew by 16% year-over-year, while its international business expanded by over 17-fold, bolstered by the recent acquisition of Eucalyptus. These results reflect the company's continued acceleration in growth and its expanding global reach.

Filer
Hims & Hers Health, Inc. HIMS · NYSE
Filed
Accession
0001773751-26-000161
CIK
0001773751
Signal
High impactConsumer Defensive

Items reported

Item events

Reported Item

Earnings Beat Raised Guidance

Market reaction

Close before filing

$31.60

Since filing

+0.0%

Latest close

$31.60

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from HIMS reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, HIMS insiders reported 6 Form 4 transactions — net selling of $419K.

Full HIMS insider history →

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.

Exchange NYSE Industry Household & Personal Products Company website ↗

Never miss another HIMS filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts